ance, is also thought to promote abnormal coronary endothelial dysfunction, as well as the release of inflammatory and vasoconstrictive substances. [9] [10] [11] [12] Therefore, we postulated that optimal control of postprandial hyperglycemia would improve not only the culprit, but also nonculprit, epicardial CBF. We examined this hypothesis using CTFC, which is a simple clinical tool for quantifying epicardial CBF as an index of coronary vascular resistance, and investigated whether optimal control of postprandial hyperglycemia improves pan-CBF in patients with ACS who have undergone successful coronary intervention.
Methods

Study Population
A total of 324 consecutive ACS patients who had a successful coronary intervention underwent a 75-g oral glucose tolerance tests (OGTT). Obvious diabetic patients actively being treated with oral hypoglycemia agents or insulin, patients with heart failure, active inflammatory disease, or severe hepatic or renal disease were excluded from this study. The diagnosis of postprandial hyperglycemia was based on the criteria of the American Diabetes Association, using the fasting and 2-h plasma glucose values obtained from the 75-g OGTT. 13 Postprandial hyperglycemia is defined as fasting plasma glucose level <7.0 mmol/L and 2-h plasma glucose level ≥7.8 mmol/L. Of the study population, 109 patients were identified as having postprandial hyperCirc J 2007; 71: 1079 -1085 (Received February 20, 2007 ; revised manuscript received March 15, 2007;  accepted March 30, 2007) Division of Cardiovascular Medicine, Ohashi Hospital, Toho University School of Medicine, Tokyo, Japan Mailing address: Raisuke Iijima, MD, Division of Cardiovascular Medicine, Ohashi Hospital, Toho University School of Medicine, 2-17-6 Ohashi, Meguro-ku, Tokyo 153-8515, Japan. E-mail: Raisuke 329@aol.com
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glycemia (diabetic pattern, 55 patients; normal pattern, 160 patients). All patients received information and dietary lifestyle recommendations, and the status of their glucose tolerance and medical condition was followed up monthly at the outpatient clinic of Toho Ohashi hospital. At 8 months after procedures, 29 patients were excluded because of either the presence of flow-limiting stenosis in the culprit or nonculprit arteries (n=15), or no follow-up angiography (n=14). Therefore, the final study population consisted of 80 patients.
These 80 patients underwent a second coronary angiography study and 75-g OGTT at an average duration of 8.1±1.9 months after procedure. The patients were divided according to the postprandial glucose level after the 75-g OGTT: suboptimal control of postprandial hyperglycemia was defined as 2-h plasma glucose level ≥7.8 mmol/L (n= 40), and optimal control as <7.8 mmol/L (n=40). Changes in the CTFC of the culprit/nonculprit arteries, body mass index (BMI), glucose response, high sensitive-C reactive protein (hs-CRP) and other clinical variables were compared. Information was obtained from a database that included demographics and procedural data entered at the time of the procedures and updated by an independent investigator (R.N.) during this investigation. Written informed consent was given by all patients participating in the study.
Blood Sampling and OGTT
Blood samples were drawn at baseline and 8 months after the procedure. Immediately after admission, venous blood samples were obtained to measure ratios (%) of hemoglobin A1c, total cholesterol, triglycerides and hs-CRP before any medical agents or other interventions were administered. Serum hs-CRP was measured in plasma stored at -80°C using the DadeBehring N-latex-enhanced CRPII on a Behring nephelometer-BNII (Dade Behring, Inc, Deerfield, IL, USA). The upper and lower limits of detection are 0.500 and 0.004 mg/dl, respectively. We also used commercially available testing kits to measure blood glucose, total cholesterol, and creatinine phosphokinase. The baseline 75-g OGTT was performed at 2-3 weeks after coronary intervention to avoid the possible influence of ACS on glucose tolerance. Blood samples were withdrawn after a 12-h overnight fast. Initially, 75 g of glucose was orally administered over a period of 5 min and then plasma glucose and insulin levels were measured before, 30 min, 60 min and 2 h later. Insulin resistance was also estimated by homeostasis model assessment (HOMA) index (fasting plasma glucose [mmol/L] × fasting plasma insulin [ U/ml]/ 22.5).
Evaluation of CBF
All patients underwent coronary angiography immediately and at 8 months after procedures. The culprit lesion was defined as the one that was dilated during coronary intervention. CBF in the culprit and nonculprit arteries was objectively quantified using the TIMI frame count, by 2 independent observers who were unaware of the clinical details of individual patients. The mean TIMI frame count for the nonculprit lesion was calculated by adding the TIMI frame count for the other major coronary arteries and then dividing the value by 2. This method has been validated and proposed as a simple, reproducible, objective and quantitative index of CBF that allows standardization of TIMI flow grades. A higher TIMI frame count may reflect disordered vessel resistance. [14] [15] [16] Briefly, the number of cineangiographic frames (recorded at 25 frames/s) required for the leading edge of the column of radiographic contrast to reach a predetermined landmark is determined. The first frame is defined as that in which concentrated dye occupies the full width of the proximal coronary artery lumen, touching both of its borders, and having forward motion down the artery. The final frame is designated when the leading edge of the contrast column initially arrives at the distal landmark. In the left anterior descending coronary artery, the landmark is the most distal branch nearest the apex of the left ventricle, commonly referred as the "pitchfork" or "whale's tail." The left anterior descending coronary artery is usually longer than the other major coronary arteries, and the TIMI frame count for this vessel is often higher. To obtain the CTFC for the left anterior descending coronary artery, the TIMI frame count was divided by 1.7. The right coronary artery distal landmark is the first branch of the posterolateral right coronary artery after the origin of the posterior descending artery, regardless of the size of this branch. The branch of the left circumflex artery that encompassed the greatest total distance travelled by contrast defined the distal landmark of this artery. The TIMI frame counts in the left anterior descending coronary artery and left circumflex artery were assessed in a right anterior oblique projection with caudal angulation, and the right coronary artery were assessed in a left anterior oblique projection with cranial angulation.
Quantitative Coronary Angiographic Analysis
Quantitative coronary angiography (QCA) was performed by experienced interventional cardiologists using the automated edge detection system CMS (Medis Medical Imaging Systems, Nuenen, The Netherlands). QCA was performed before, immediately, and 8 months after the procedures using edge detection algorithms. Minimal lumen diameter, reference vessel diameter, diameter of stenosis, and lesion length were measured.
Statistical Analysis
Results are presented as means ± SD, or n (%). Comparisons between groups were performed using the chi square test or the Fisher exact test for categorical data. Continuous variables were compared using the paired Student's t-test. The correlation between mean CTFC and biochemical values and clinical variables was assessed by Pearson's or Spearman's correlation tests. Differences between baseline and at 8 months in plasma glucose levels, BMI, plasma insulin levels, and hs-CRP levels were analyzed by repeated measures ANOVA. A p-value of 0.05 was considered statistically significant.
Results
Age, gender, BMI, and coronary risk factors did not significantly differ between the 2 groups. More patients in the optimal control group were medicated with pioglitazone after procedure and most patients in both groups were administered aspirin and statins. Any other hypoglycaemia agents or insulin were not used. Baseline biochemical values in both groups were similar, including total cholesterol, triglycerides, hemoglobin A1c, and hs-CRP. The fasting and 2-h postprandial glucose values after OGTT did not significantly differ between the groups ( at initial angiography were similar in both groups. The % diameter stenosis before the procedure was significantly higher in the optimal, than in the suboptimal control group, but reference diameter, % diameter stenosis immediately and at 8 months after procedures did not significantly differ (Table 2) . Fig 1 summarizes the CTFC at baseline and at 8-month angiography in the culprit and nonculprit arteries. The CTFC did not significantly differ between the optimal and suboptimal control groups in culprit (30±9 vs 29±10, p= 0.70) or nonculprit arteries (26±9 vs 27±8, p=0.66). The 8-month angiogram revealed a significantly improved CTFC in the culprit arteries of the optimal control group compared with the baseline values (30±9 vs 24±12, p= 0.048). In contrast, the CTFC of the suboptimal control group did not show such an improvement and subsequently the CTFC at 8 months was significantly lower in the optimal, than in the suboptimal control group (24±12 vs 30±11, p=0.027). On the other hand, the CTFC increased significantly from 27±8 at baseline to 30±10 (p=0.05) 8 months later in the nonculprit arteries of the suboptimal control group. Similarly, the CTFC was significantly lower in the optimal, than in the suboptimal control group, even in nonculprit arteries (25±10 vs 30±10, p=0.035). Figs 2 and 3 show the changes in the various parameters of the optimal and suboptimal control groups. After 8 months, patients with optimal control of postprandial glucose achieved significant reductions in fasting plasma glucose levels (from 5.27±0.55 mmol/L to 4.92±1.00 mmol/L, p=0.05), 2-h postprandial glucose (from 9.16±3.05 mmol/L to 6.23± 1.90 mmol/L, p<0.0001), 2-h postprandial insulin levels (from 144.7±108.7 U/L to 79.5±84.7 U/L, p=0.004), BMI 
Postprandial Glucose and CTFC
Table 3 Results of Glucose Tolerance Test and Biochemical Values at 8 Months After Procedures
Data are means ± SD or ratio (%) of patients. Abbreviations as in Table 1 . (from 24.2±3.8 to 23.1±3.3, p=0.002) and hs-CRP levels (from 0.194±0.227 mg/dl to 0.066±0.099 mg/dl, p<0.001) compared with baseline values. As shown in Table 3 , the HOMA index at 8 months after procedures was significantly lower in the optimal group compared with the suboptimal group. Other biochemical values at 8 months, including hemoglobin A1c, total cholesterol, and triglyceride, were similarly reduced in both groups. The CTFC at 8 months significantly correlated with BMI (r=0.25, p=0.03), 2-h postprandial glucose (r=0.26, p=0.04), and 2-h postprandial insulin (r=0.29, p=0.02). The fasting plasma glucose and hs-CRP levels did not reach significance (Table 4) .
Discussion
The CTFC is a simple tool for quantifying epicardial CBF because it reflects coronary vascular resistance. [14] [15] [16] Several investigators have reported that a global flow abnormality affecting the entire coronary tree is associated with adverse clinical outcomes in patients with ACS. Additionally, several studies have shown the widespread vulnerability of both culprit and nonculprit lesions. [3] [4] [5] 8 These findings suggest that global coronary vulnerability should be stabilized in order to reduce adverse clinical events in ACS patients who have undergone successful coronary intervention. The first DIGAMI study found that glucose homeostasis affects prognosis after an acute myocardial infarction, and that intensive glucose control following a myocardial infarction can significantly improve long-term prognosis. 17 The present study demonstrated that optimal control of postprandial hyperglycemia at 8 months after a successful procedure improves the CTFC in the coronary arteries. In contrast, the CTFC in the culprit and nonculprit arteries did not improve in patients with suboptimal control of postprandial hyperglycemia. The deteriorated CBF with suboptimal control of postprandial hyperglycemia may be caused by unstable plaque and impaired endothelial function in all the coronary arteries.
Postprandial Hyperglycemia and Endothelial Function
Conditions such as postprandial hyperglycemia and impaired glucose tolerance are associated with increased cardiovascular morbidity and mortality. Epidemiological studies show that postprandial hyperglycemia is an independent risk factor for cardiovascular disease in individuals with impaired glucose tolerance and type II diabetes. [9] [10] [11] [18] [19] [20] The DECODE study over a mean follow-up of 7.3 years showed that 2-h post-challenge glucose levels correlate with the risk of mortality after adjustment for fasting plasma glucose values. In contrast, fasting plasma glucose levels are not independently related to a risk of death after adjustment for 2-h post-challenge glucose levels. 21 One explanation is that cardiovascular events in patients with postprandial hyperglycemia might be caused by endothelial dysfunction. Endothelium-derived nitric oxide (NO) is 1 of the most potent known endogenous vasodilators and it plays an important role in the control of CBF by regulating vascular tone. Thus, endothelial dysfunction results in an imbalance between relaxing and contracting factors, prothrombotic state, inflammatory response, vasoconstrictive substance release, and subsequent plaque instability in the coronary arteries. [22] [23] [24] Studies in vitro have also shown that an intermittent or constantly high glucose concentration induces endothelial cell death and loss of functional endothelium. 25, 26 Risso et al 27 explored the effect of incubating human umbilical vein endothelial cells in media containing normal, continuously high or alternating normal and high levels of glucose every 24 h. Their results showed that fluctuating glucose levels in the media produced a significant increase in endothelial cell death compared with cells in media containing constantly high levels. Although the molecular mechanisms triggered in cultured endothelial cells by periodically changing glucose concentrations are unknown, several effects on intracellular signaling pathways, including glucose-induced oxidative stress, as well as activation of both calcium channels and protein kinase C, could be involved in endothelial cell death. Thus, improving postprandial hyperglycemia seems to favorably affect endothelial function in all the coronary arteries, and may contributed to an improved long-term prognosis. Another finding from the present study is that the CTFC at 8 months positively correlated with BMI, as well as the 2-h postprandial glucose and insulin levels. Previous studies have shown that weight loss improves the resistance of the arterial endothelium and decreases the levels of circulating markers of endothelial damage. [28] [29] [30] [31] [32] Raitakari et al 33 described improved dilation of the brachial artery mediated by flow in 67 nondiabetic obese adults after consuming a very low calorie diet for 6 weeks. They concluded that this improvement was related only to a decrease in the blood glucose level, and that it occurred independently of all other metabolic improvements. Our findings are consistent with those.
Study Limitations
First, the HOMA index at 8 months after procedures significantly improved in the optimal group compared with the suboptimal group. Therefore, the use of pioglitazone might positively affect endothelial function and coronary vascular resistance, but we could not determine this because only a few patients were administered this drug. 34 Second, we did not assess endothelial function by measuring flow-mediated dilation, nor did we measure waist and hip circumference, which are used to assess the profile of metabolic syndrome. Finally, although all patients received information and dietary lifestyle recommendations during the study, we did not use intense exercise or dietary protocols to reduce body weight.
In conclusion, optimal control of postprandial hyperglycemia improves pan-CBF and this positive effect might be related to improved coronary endothelial function. Our findings suggest that improved postprandial hyperglycemia, lifestyle changes and weight loss appear to be important for improving epicardial flow of the entire coronary tree after ACS. However, prospective evaluations are needed to prove the clinical effect relationship between optimal control of postprandial hyperglycemia and improved CBF.
